NORTHVALE, N.J., April 29, 2008 (PRIME NEWSWIRE) -- Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (AMEX:ELI), announced the appointment of Stuart Apfel M.D., its current Chief Medical Officer as its Chief Scientific Officer. Dr. Apfel will replace Dr. Veerappan Subramanian, who has been Elite’s acting Chief Scientific Officer since February 9, 2007.
